Crohn’s disease | Ulcerative colitis | Arthritis (SpA) | |
---|---|---|---|
Patients (Ν) | 34 | 26 | 14 |
Sex (M/F) | 22/12 | 15/11 | 11/3 |
Age (years) | |||
Median [range] | 32.5 [18–61] | 42.5 [23–70] | 34.5 [23–65] |
BMI | |||
Median [range] | 23.2 [18–34] | 25.7 [19–31] | 24.9 [18–28] |
Disease duration (years) | |||
Median [range] | 2 [0.1–20] | 3 [0.1–30] | 4 [0.2–20] |
Disease localization | |||
Small bowel | 10 | 3 | |
Large bowel | 8 | 26 | 2 |
Small and large bowel | 16 | 2 | |
IBD activity | |||
Active | 20 | 20 | – |
Inactive | 14 | 6 | 7 |
Arthritis | 10 | 8 | |
Active | 5 | 4 | 10 |
Inactive | 5 | 4 | 4 |
Medications | |||
ASA | 24 | 25 | 3 |
Corticosteroids | 26 | 10 | 5 |
AZA | 13 | 5 | 0 |
MTX | 0 | 0 | 4 |
Anti-TNF | 17 | 1 | 4 |
Combi medication (%) | 28 (82) | 13 (50) | 2 (14) |